arrow
Back
C

Christophe Pannecouque

ku leuven

71H-index
757Paper Count
2.0WCitation Count
Published Papers 354
Publication Date
Surface Plasmon Resonance as a Potential Diagnostic Tool for the Detection of CXC Chemokine Receptor 4 (CXCR4) on Extracellular Vesicles
err2026-03-28
err0
errOAAI
errKaat Verleye; Sam Noppen; Arnaud Boonen; Yagmur Yildizhan; Tom Van Loy; Cindy Heens; Frank Vanderhoydonc; Cláudio Pinheiro; Paula M. Pincela Lins; Annelies Bronckaers; An Hendrix; Johannes V. Swinnen; Dragana Spasic; Jeroen Lammertyn; Christophe Pannecouque; Dominique Schols
errShare
errSave
Rational Design of Broad-Spectrum Non-Nucleoside Reverse Transcriptase Inhibitors via Pharmacophore-Oriented Generative Artificial Intelligence
err2026-03-01
err1
PREAI
errZhang, Kun; Lin, Yuhan; Dong, Ling; Niu, Yuting; Peng, Jian; Pannecouque, Christophe; De Clercq, Erik; Tran, Phuong-Thao; Li, Guobo; Zhao, Tiancong; Li, Xudong; Su, Shuo; Wang, Shuai; Chen, Fen-Er
errShare
errSave
Discovery of novel diarylpyrimidine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors: Design, synthesis and biological activity evaluation
err2026-01-04
err0
PREAI
errHao Lin; Zhongxia Zhou; Lin Zheng; Ying Liu; Da Feng; Xiangyi Jiang; Yanying Sun; Xiangkai Ji; Erik De Clercq; Christophe Pannecouque; Chin-Ho Chen; Dongwei Kang; Peng Zhan; Xinyong Liu
errShare
errSave
Coumarin-stavudine (d4T) novel hybrid ProTides with dual-functionality and enhanced anti-HIV activity
err2025-12-30
err0
errOAAI
errSahar B. Kandil; Katie S. Jones; Christophe Pannecouque; Andrew D. Westwell
errShare
errSave
Correction to “Exploring the HIV-1 Reverse Transcriptase p51/p66 Interface: Structure-Based Design and Optimization of Novel 2; 4; 6-Trisubstituted Pyrimidines as Potent NNRTIs with Improved Resistance Profiles”
err2025-10-23
err0
errOAAI
errXiangkai Ji; Xiangyi Jiang; Zhen Gao; Heng Gao; Xing Huang; Fabao Zhao; Erik De Clercq; Zhao Wang; Christophe Pannecouque; Dongwei Kang; Peng Zhan; Xinyong Liu
errShare
errSave
Design, synthesis, and biological evaluation of dual-site HIV-1 inhibitors simultaneously targeting the NNRTI binding pocket and an adjacent site with favorable resistance profiles
err2025-08-26
err0
PREAI
errXiangkai Ji; Xiangyi Jiang; Xing Huang; Heng Gao; Zhen Gao; Ping Gao; Erik De Clercq; Christophe Pannecouque; Dongwei Kang; Peng Zhan; Xinyong Liu
errShare
errSave
Halogenation-Driven Discovery of Halomethylene-Biphenyl-Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Safety and PK Profiles
err2025-07-26
err0
PREAI
errXiao-Mei Chen; Qian Xu; Christophe Pannecouque; Erik De Clercq; Enzo Tramontano; Phuong-Thao Tran; Shuai Wang; Fen-Er Chen
errShare
errSave
Further exploring the tolerant region II: Identification of 2,4,5-trisubstituted pyrimidines as HIV-1 reverse transcriptase allosteric inhibitors with desirable antiviral activities and reduced cytotoxicity
err2025-07-21
err0
PREAI
errZhenzhen Zhou; Lin Zheng; Wenbo Jiang; Wenbo Zhang; Fabao Zhao; Zhening Liang; Erik De Clercq; Christophe Pannecouque; Peng Zhan; Dongwei Kang; Xinyong Liu
errShare
errSave
Probing the Dominant Motifs within the Hydrophobic Channel Yields Oxadiazole-Containing Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
err2025-07-17
err0
PREAI
errTao Zhang; Yue Yang; Xin Li; Fabao Zhao; Zongji Zhuo; Le Wang; Wenbo Zhang; Erik De Clercq; Christophe Pannecouque; Peng Zhan; Dongwei Kang; Xinyong Liu
errShare
errSave
Rational structure-based design and optimization of next-generation biphenyl-piperidine-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors
err2025-05-21
err0
PREAI
errKun Zhang; Li-Min Zhao; Tianhao Xing; Yueyue Bu; Qingyun Wang; Christophe Pannecouque; Erik De Clercq; Angela Corona; Laura Dettori; Enzo Tramontano; Shuai Wang; Fen-Er Chen
errShare
errSave
Design, Synthesis and Biological Evaluation of 3-Hydrazonoindolin-2-one Derivatives as Novel HIV-1 RNase H Inhibitors
err2025-04-22
err0
errOAAI
errZhang, Yiying; Wang, Rao; Bu, Yueyue; Corona, Angela; Dettori, Laura; Tramontano, Enzo; Pannecouque, Christophe; De Clercq, Erik; Meng, Ge; Chen, Fen-Er
errShare
errSave
errShare
errSave
Structure-based discovery of novel diarylpyrimidines as potent and selective Non-Nucleoside reverse transcriptase inhibitors: From CH (CN)-Biphenyl-Diarylpyrimidines to C.905em-1NNH2-Biphenyl- Diarylpyrimidines
err2025-03-01
err0
PREAI
errChen, Xiao-Mei; Pannecouque, Christophe; De Clercq, Erik; Lian, Yu-Xuan; Corona, Angela; Dettori, Laura; Tramontano, Enzo; Wang, Shuai; Chen, Fen-Er
errShare
errSave
Structure-based design of novel 2,4,5-trisubstituted pyrimidine derivatives as potent HIV-1 NNRTIs by exploiting the tolerant regions in NNTRIs binding pocket
err2025-02-01
err0
PREAI
errZhou, Zhenzhen; Xie, Minghui; Zhuo, Zongji; Wang, Yalin; Zhao, Fabao; Tao, Sining; Liang, Zhening; De Clercq, Erik; Pannecouque, Christophe; Zhan, Peng; Kang, Dongwei; Liu, Xinyong
errShare
errSave
Discovery of novel fused-heterocycle-bearing diarypyrimidine derivatives as HIV-1 potent NNRTIs targeting tolerant region I for enhanced antiviral activity and resistance profile
err2025-01-01
err1
PREAI
errDai, Jiaojiao; Jiang, Xiangyi; Gao, Heng; Huang, Boshi; De Clercq, Erik; Pannecouque, Christophe; Du, Shaoqing; Liu, Xinyong; Zhan, Peng
errShare
errSave
errShare
errSave
Identification of novel diarylpyrimidine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against wild-type and K103N mutant viruses
err2024-12-01
err1
PREAI
errJiang, Xiangyi; Zalloum, Waleed A.; Gao, Zhen; Dai, Jiaojiao; Ji, Xiangkai; Xie, Minghui; Dong, Guanyu; De Clercq, Erik; Huang, Boshi; Pannecouque, Christophe; Zhan, Peng; Liu, Xinyong
errShare
errSave